Kenjiro Aogi Selected Research

dofequidar (MS 209)

2/2007

Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenjiro Aogi Research Topics

Disease

113	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2002
44	Neoplasms (Cancer) 01/2022 - 01/2002
14	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2005
8	Nausea 01/2021 - 02/2009
8	Vomiting 01/2021 - 02/2009
7	Neutropenia 07/2021 - 08/2008
6	Lymphatic Metastasis 01/2021 - 01/2005
4	Triple Negative Breast Neoplasms 01/2022 - 01/2019
4	Alopecia (Baldness) 10/2021 - 12/2015
4	Disease Progression 07/2021 - 11/2009
3	Carcinoma (Carcinomatosis) 07/2022 - 03/2016
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 01/2006
3	Febrile Neutropenia 01/2019 - 08/2009
3	Leukopenia 10/2016 - 08/2008
2	Diarrhea 10/2016 - 12/2015
2	Ductal Carcinoma 01/2016 - 05/2015
2	Unilateral Breast Neoplasms 07/2013 - 07/2013
2	Constipation 08/2011 - 02/2009
2	Stomach Neoplasms (Stomach Cancer) 11/2010 - 04/2010
1	Thrombosis (Thrombus) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Fatigue 01/2021
1	Medically Unexplained Symptoms 03/2020
1	Body Weight (Weight, Body) 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020

Drug/Important Bio-Agent (IBA)

22	Hormones (Hormone)IBA 11/2020 - 12/2009
17	Estrogen ReceptorsIBA 05/2022 - 04/2011
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2020 - 01/2005
15	AnthracyclinesIBA 07/2021 - 06/2005
13	Trastuzumab (Herceptin)FDA Link 09/2021 - 03/2005
13	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 01/2009
13	Tamoxifen FDA LinkGeneric 01/2021 - 01/2005
10	human ERBB2 proteinIBA 05/2022 - 02/2012
10	Docetaxel (Taxotere)FDA Link 07/2021 - 03/2005
9	taxaneIBA 07/2021 - 08/2006
8	Progesterone Receptors (Progesterone Receptor)IBA 05/2015 - 04/2011
7	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 01/2005
7	Epirubicin (Ellence)FDA LinkGeneric 04/2020 - 01/2005
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 12/2003
6	ErbB Receptors (EGF Receptor)IBA 11/2018 - 10/2012
6	Capecitabine (Xeloda)FDA Link 08/2018 - 08/2006
6	exemestane (Aromasin)FDA Link 03/2016 - 12/2009
5	Vinorelbine (Navelbine)FDA LinkGeneric 07/2021 - 06/2005
5	Aromatase InhibitorsIBA 11/2014 - 06/2010
4	Anastrozole (Arimidex)FDA LinkGeneric 09/2021 - 06/2010
4	eribulin FDA Link 07/2021 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2020 - 10/2011
4	Palonosetron (Aloxi)FDA Link 01/2020 - 02/2009
4	Taxoids (Taxanes)IBA 01/2019 - 06/2005
4	Estrogens (Estrogen)FDA Link 12/2013 - 10/2011
3	Lapatinib (GW572016)FDA Link 08/2021 - 12/2015
3	130-nm albumin-bound paclitaxelIBA 07/2021 - 04/2015
3	SteroidsIBA 01/2021 - 10/2011
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 02/2009
3	Pharmaceutical PreparationsIBA 01/2020 - 10/2008
3	Granisetron (Kytril)FDA LinkGeneric 01/2020 - 02/2009
3	Monoclonal AntibodiesIBA 12/2016 - 02/2009
3	Gemcitabine FDA Link 10/2013 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 08/2013 - 02/2009
3	Toremifene (Fareston)FDA Link 12/2009 - 01/2009
2	Fulvestrant (Faslodex)FDA Link 05/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
2	Carboplatin (JM8)FDA LinkGeneric 04/2020 - 06/2014
2	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2015
2	TabletsIBA 10/2019 - 01/2019
2	olaparibIBA 10/2019 - 01/2019
2	Albumin-Bound Paclitaxel FDA Link 05/2017 - 04/2015
2	Biological ProductsIBA 04/2016 - 09/2013
2	Phenobarbital (Luminal)FDA Link 01/2016 - 02/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 02/2009
2	UracilIBA 09/2014 - 01/2005
2	TegafurIBA 09/2014 - 01/2005
2	orantinib (SU6668)IBA 01/2014 - 08/2013
2	Tyrosine Kinase InhibitorsIBA 01/2014 - 08/2013
2	Epidermal Growth Factor (EGF)IBA 08/2013 - 01/2012
2	Transcription Factors (Transcription Factor)IBA 08/2012 - 10/2011
2	Progesterone FDA LinkGeneric 08/2012 - 10/2011
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 08/2012 - 10/2011
2	Alanine Transaminase (SGPT)IBA 08/2011 - 02/2009
1	pegfilgrastim (Neulasta)FDA Link 06/2021
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	AntiemeticsIBA 01/2021
1	afimoxifene (hydroxytamoxifen)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	UbiquitinIBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	fosaprepitant FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020

Therapy/Procedure

57	Therapeutics 07/2022 - 01/2002
28	Drug Therapy (Chemotherapy) 10/2021 - 03/2005
10	Neoadjuvant Therapy 04/2022 - 02/2012
9	Radiotherapy 01/2022 - 01/2002
8	Adjuvant Chemotherapy 10/2021 - 01/2005
8	Lymph Node Excision (Lymph Node Dissection) 08/2021 - 01/2009
7	Mastectomy (Mammectomy) 08/2019 - 01/2003
2	Time-to-Treatment 05/2022 - 01/2018
2	Segmental Mastectomy (Lumpectomy) 01/2022 - 01/2006
1	Secondary Prevention 10/2021
1	Simple Mastectomy 09/2021